Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Progress toward curing HIV infections with hematopoietic stem cell transplantation.

Smiley ST, Singh A, Read SW, Sharma OK, Finzi D, Lane C, Rice JS.

Clin Infect Dis. 2015 Jan 15;60(2):292-7. doi: 10.1093/cid/ciu766. Epub 2014 Oct 1. Review.

2.

Viral alteration of cellular translational machinery increases defective ribosomal products.

Berglund P, Finzi D, Bennink JR, Yewdell JW.

J Virol. 2007 Jul;81(13):7220-9. Epub 2007 Apr 25.

3.

Defining and solving the essential protein-protein interactions in HIV infection.

Finzi D, Dieffenbach CW, Basavappa R.

J Struct Biol. 2007 May;158(2):148-55. Epub 2006 Nov 9. Review.

PMID:
17175170
4.

Defective virus drives human immunodeficiency virus infection, persistence, and pathogenesis.

Finzi D, Plaeger SF, Dieffenbach CW.

Clin Vaccine Immunol. 2006 Jul;13(7):715-21. Review. No abstract available.

5.

Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells.

Siliciano JD, Kajdas J, Finzi D, Quinn TC, Chadwick K, Margolick JB, Kovacs C, Gange SJ, Siliciano RF.

Nat Med. 2003 Jun;9(6):727-8. Epub 2003 May 18.

PMID:
12754504
6.

Quantitating protein synthesis, degradation, and endogenous antigen processing.

Princiotta MF, Finzi D, Qian SB, Gibbs J, Schuchmann S, Buttgereit F, Bennink JR, Yewdell JW.

Immunity. 2003 Mar;18(3):343-54.

7.

Biphasic decay of latently infected CD4+ T cells in acute human immunodeficiency virus type 1 infection.

Blankson JN, Finzi D, Pierson TC, Sabundayo BP, Chadwick K, Margolick JB, Quinn TC, Siliciano RF.

J Infect Dis. 2000 Dec;182(6):1636-42. Epub 2000 Nov 8.

PMID:
11069234
8.

Antiretroviral resistance during successful therapy of HIV type 1 infection.

Martinez-Picado J, DePasquale MP, Kartsonis N, Hanna GJ, Wong J, Finzi D, Rosenberg E, Gunthard HF, Sutton L, Savara A, Petropoulos CJ, Hellmann N, Walker BD, Richman DD, Siliciano R, D'Aquila RT.

Proc Natl Acad Sci U S A. 2000 Sep 26;97(20):10948-53.

9.

Characterization of chemokine receptor utilization of viruses in the latent reservoir for human immunodeficiency virus type 1.

Pierson T, Hoffman TL, Blankson J, Finzi D, Chadwick K, Margolick JB, Buck C, Siliciano JD, Doms RW, Siliciano RF.

J Virol. 2000 Sep;74(17):7824-33.

10.

Taking aim at HIV replication.

Finzi D, Siliciano RF.

Nat Med. 2000 Jul;6(7):735-6. No abstract available.

PMID:
10888911
11.

A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children.

Persaud D, Pierson T, Ruff C, Finzi D, Chadwick KR, Margolick JB, Ruff A, Hutton N, Ray S, Siliciano RF.

J Clin Invest. 2000 Apr;105(7):995-1003.

12.

Treatment of human immunodeficiency virus infection with hydroxyurea, didanosine, and a protease inhibitor before seroconversion is associated with normalized immune parameters and limited viral reservoir.

Lori F, Jessen H, Lieberman J, Finzi D, Rosenberg E, Tinelli C, Walker B, Siliciano RF, Lisziewicz J.

J Infect Dis. 1999 Dec;180(6):1827-32.

PMID:
10558937
13.

Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy.

Finzi D, Blankson J, Siliciano JD, Margolick JB, Chadwick K, Pierson T, Smith K, Lisziewicz J, Lori F, Flexner C, Quinn TC, Chaisson RE, Rosenberg E, Walker B, Gange S, Gallant J, Siliciano RF.

Nat Med. 1999 May;5(5):512-7.

PMID:
10229227
14.

HIV-1 suppression by early treatment with hydroxyurea, didanosine, and a protease inhibitor.

Lisziewicz J, Jessen H, Finzi D, Siliciano RF, Lori F.

Lancet. 1998 Jul 18;352(9123):199-200. No abstract available.

PMID:
9683211
15.

Viral dynamics in HIV-1 infection.

Finzi D, Siliciano RF.

Cell. 1998 May 29;93(5):665-71. Review. No abstract available.

16.

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy.

Finzi D, Hermankova M, Pierson T, Carruth LM, Buck C, Chaisson RE, Quinn TC, Chadwick K, Margolick J, Brookmeyer R, Gallant J, Markowitz M, Ho DD, Richman DD, Siliciano RF.

Science. 1997 Nov 14;278(5341):1295-300.

17.

Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection.

Chun TW, Carruth L, Finzi D, Shen X, DiGiuseppe JA, Taylor H, Hermankova M, Chadwick K, Margolick J, Quinn TC, Kuo YH, Brookmeyer R, Zeiger MA, Barditch-Crovo P, Siliciano RF.

Nature. 1997 May 8;387(6629):183-8.

PMID:
9144289
18.

In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency.

Chun TW, Finzi D, Margolick J, Chadwick K, Schwartz D, Siliciano RF.

Nat Med. 1995 Dec;1(12):1284-90.

PMID:
7489410
19.

Studies of the mechanism of cytolysis by HIV-1-specific CD4+ human CTL clones induced by candidate AIDS vaccines.

Miskovsky EP, Liu AY, Pavlat W, Viveen R, Stanhope PE, Finzi D, Fox WM 3rd, Hruban RH, Podack ER, Siliciano RF.

J Immunol. 1994 Sep 15;153(6):2787-99.

PMID:
7915742
20.

Responses of mice to murine coronavirus immunization.

Smith AL, de Souza MS, Finzi D, Barthold SW.

Arch Virol. 1992;125(1-4):39-52.

PMID:
1322658

Supplemental Content

Support Center